STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines

Andrey Zarur, CEO of GreenLight Biosciences, writes for STAT about the vaccine supply chain and how we need to work together to make Covid-19 vaccines.


Andrey Zarur, CEO of GreenLight Biosciences, wrote for STAT about the Covid-19 vaccine supply chain. He explains how business competitors need to work together to beat the virus. An extract from his opinion piece is below:

While RNA science has been developing for two decades, this is the first time we have needed to make billions of doses ASAP. Ingredients for these mRNA vaccines that were stockpiled in advance of FDA approval will be enough to cover the first billion doses or so. Bottlenecks will emerge after that.

I’d like to help. My company and others can, in fact, help by breaking a number of production bottlenecks with our technologies, facilities, and staff. But for now we can only stand by because we don’t know what the bottlenecks are. We do know one thing: Our help is needed — no one company can solve this alone.

Now is not the time for those involved in developing and manufacturing Covid-19 vaccines to hold their cards tightly to their chests. We must work together and commit to helping each other: Our enemy is the virus, not our business competitors. We welcome the offer by Ugur Sahin, CEO of BioNTech, to cooperate with other companies. The entire industry needs to work together.

Read the full article here.

Find out more about how GreenLight manufactures RNA here.